oci aml3 Search Results


oci aml3  (DSMZ)
96
DSMZ oci aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3, supplied by DSMZ, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/OCI-AML3/pmc13032267-47-16-23
Average 96 stars, based on 1 article reviews
oci aml3 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
oci-aml3  (SMAC Corp)
90
SMAC Corp oci-aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3, supplied by SMAC Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3/pmc09185151-13-16-0
Average 90 stars, based on 1 article reviews
oci-aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci-aml3 cell line  (BioWhittaker Molecular Applications)
90
BioWhittaker Molecular Applications oci-aml3 cell line
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3 Cell Line, supplied by BioWhittaker Molecular Applications, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3+cell+line/pmc05061470-308-1-16
Average 90 stars, based on 1 article reviews
oci-aml3 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci-aml3  (BioWare Corporation)
90
BioWare Corporation oci-aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3, supplied by BioWare Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3/pmc04457455-43-0-16
Average 90 stars, based on 1 article reviews
oci-aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
cell line oci-aml3  (Promega)
90
Promega cell line oci-aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Cell Line Oci Aml3, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/cell+line+oci+aml3/pmc07367172-29-0-35
Average 90 stars, based on 1 article reviews
cell line oci-aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci-aml3  (Corning Life Sciences)
90
Corning Life Sciences oci-aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3, supplied by Corning Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3/pm38136410-49-0-5
Average 90 stars, based on 1 article reviews
oci-aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci-aml3 cells  (Welgene inc)
90
Welgene inc oci-aml3 cells
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3 Cells, supplied by Welgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3+cells/pm37495419-42-0-8
Average 90 stars, based on 1 article reviews
oci-aml3 cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci/aml3  (Hayashibara Biochemical Laboratories)
90
Hayashibara Biochemical Laboratories oci/aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci/Aml3, supplied by Hayashibara Biochemical Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3/pmc02840060-37-23-49
Average 90 stars, based on 1 article reviews
oci/aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human aml cell line oci-aml3  (ScienCell)
90
ScienCell human aml cell line oci-aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Human Aml Cell Line Oci Aml3, supplied by ScienCell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/human+aml+cell+line+oci+aml3/pmc07225231-47-1-6
Average 90 stars, based on 1 article reviews
human aml cell line oci-aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci-aml3  (Bioarray Inc)
90
Bioarray Inc oci-aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3/10__1097_slash_aap__0000000000000191-31-19-21
Average 90 stars, based on 1 article reviews
oci-aml3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci-aml3 cell line  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare oci-aml3 cell line
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3 Cell Line, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3+cell+line/pm28574250-123-0-17
Average 90 stars, based on 1 article reviews
oci-aml3 cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
oci aml3  (Biochrom)
86
Biochrom oci aml3
The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B <t>),</t> <t>OCI-AML3</t> ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated
Oci Aml3, supplied by Biochrom, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oci+aml3/oci+aml3/us10941202-259-38-35
Average 86 stars, based on 1 article reviews
oci aml3 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B ), OCI-AML3 ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia

doi: 10.1186/s13046-026-03657-y

Figure Lengend Snippet: The antibody-drug conjugate RGX-019-MMAE induced cytotoxic activity in MERTK-expressing AML cell lines. A MERTK expression in the indicated AML cell lines; leukemic cells (1 × 10 6 ) were stained with anti-MERTK-APC antibody, and the expression was measured by flow cytometry. Data are plotted as mean values with error bars representing standard error. B - F Bar graph showing the percentage of relative luminescence in Kasumi 1 ( B ), OCI-AML3 ( C ), MOLM-13 ( D ), MOLM-14 ( E ), and MV4-11 ( F ) cells treated with the indicated concentrations of RGX-019-MMAE and monoclonal antibody RGX-019. Data are plotted as mean values with error bars representing standard error (Student unpaired t -test). * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001. UT = untreated

Article Snippet: Kasumi-1, THP-1, MV4-11, and U937 AML cells were purchased from ATCC (Manassas, VA), and MOLM-13, MOLM-14, OCI-AML3, and OCI-AML2 cells were obtained from DSMZ (Braunschweig, Germany).

Techniques: Activity Assay, Expressing, Staining, Flow Cytometry

RGX-019-MMAE in combination with venetoclax enhanced AML cell killing. A , B Bar graphs show the absolute count of live leukemic cells in OCI-AML3 ( A ) and THP-1 ( B ) cell lines treated with indicated concentrations of venetoclax, RGX-019, and/or RGX-019-MMAE. Flow cytometry was used to determine the combinatorial effects of RGX-019-MMAE or monoclonal antibody RGX-019 with venetoclax. Annexin V-FITC was used as an apoptosis marker, and cell viability was determined with DAPI. (Welch one-way ANOVA) * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001

Journal: Journal of Experimental & Clinical Cancer Research : CR

Article Title: RGX-019-MMAE inhibits leukemia progression by targeting MER proto-oncogene tyrosine kinase (MERTK) in acute myeloid leukemia

doi: 10.1186/s13046-026-03657-y

Figure Lengend Snippet: RGX-019-MMAE in combination with venetoclax enhanced AML cell killing. A , B Bar graphs show the absolute count of live leukemic cells in OCI-AML3 ( A ) and THP-1 ( B ) cell lines treated with indicated concentrations of venetoclax, RGX-019, and/or RGX-019-MMAE. Flow cytometry was used to determine the combinatorial effects of RGX-019-MMAE or monoclonal antibody RGX-019 with venetoclax. Annexin V-FITC was used as an apoptosis marker, and cell viability was determined with DAPI. (Welch one-way ANOVA) * p ≤0.05, ** p ≤0.01, *** p ≤0.001, **** p ≤0.0001

Article Snippet: Kasumi-1, THP-1, MV4-11, and U937 AML cells were purchased from ATCC (Manassas, VA), and MOLM-13, MOLM-14, OCI-AML3, and OCI-AML2 cells were obtained from DSMZ (Braunschweig, Germany).

Techniques: Flow Cytometry, Marker